NCT06652776Enrolling by invitation
The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease
The Italian COPD Registry. The DescribinG bUrden of COPD and Occurrence of mortaLity in a Cohort of Italian Patients
Source: ClinicalTrials.gov · Last updated 4 May 2026
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD) is a treatable but debilitating medical condition associated with persistent symptoms and chronic airflow obstruction. Despite the availability of multiple therapeutic options, COPD is the third leading cause of death worldwide and has a substantial socioeconomic impact. The present real life study is aimed at describing the clinical and functional characteristics, treatment patterns, impact of exacerbations and comorbidities and their association with mortality in a large cohort of Italian patients with COPD.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 3 Sept 2024
- Start date
- 30 Sept 2024
- Primary completion date
- 31 Dec 2035
- Lead sponsor
- University of Milan
- Diseases
- Heart failure, COPD
- NCT number
- NCT06652776
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 30 Sept 2024 to the primary completion date, 31 Dec 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis or clinically significant alternative respiratory diseases (such as interstitial lung disease or bronchiectasis)
Other
- Presence of current clinically significant asthma
Who the study is looking for
- established diagnosis of COPD (defined as age ≥ 40 years old, smoking history ≤ 20 pack years, postbronchodilator forced expiratory volume in one second to slow vital capacity ratio (FEV1/VC) ≤ the lower limit of normal (LLN) criteria.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Luigi Sacco University Hospital, Division of Department of Biomedical and Clinical Sciences, University of Milan Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.